John T Mitchell1, Andrea L Howard2, Katherine A Belendiuk3, Traci M Kennedy4, Annamarie Stehli5, James M Swanson5, Lily Hechtman6, L Eugene Arnold7, Betsy Hoza8, Benedetto Vitiello9, Bo Lu10, Scott H Kollins1, Brooke S G Molina11. 1. Department of Psychiatry & Behavioral Sciences, Duke University Medical Center, Durham, NC. 2. Department of Psychology, Carleton University, Ottawa, Ontario, Canada. 3. Genentech, South San Francisco, CA. 4. Department of Psychiatry, University of Pittsburgh School of Medicine, Pittsburgh, PA. 5. Department of Pediatrics, University of California, Irvine, CA. 6. Division of Child Psychiatry, McGill University, Montreal Children's Hospital, Montreal, Quebec, Canada. 7. Department of Psychiatry and Behavioral Health, Ohio State University, Columbus, OH. 8. Department of Psychological Science, University of Vermont, Burlington, VT. 9. Division of Child and Adolescent Neuropsychiatry, University of Turin, Italy. 10. Division of Biostatistics, The Ohio State University, Columbus, OH. 11. Departments of Psychiatry, Psychology, and Pediatrics, University of Pittsburgh, Pittsburgh, PA.
Abstract
INTRODUCTION: Children with attention-deficit/hyperactivity disorder (ADHD) are at increased risk for smoking cigarettes, but there is little longitudinal research on the array of smoking characteristics known to be prognostic of long-term smoking outcomes into adulthood. These variables were studied into early adulthood in a multisite sample diagnosed with ADHD combined type at ages 7-9.9 and followed prospectively alongside an age- and sex-matched local normative comparison group (LNCG). METHODS: Cigarette smoking quantity, quit attempts, dependence, and other characteristics were assessed in the longitudinal Multimodal Treatment Study of Children with ADHD (MTA) eight times to a mean age of 24.9 years: ADHD n = 469; LNCG n = 240. RESULTS: In adulthood, the ADHD group had higher rates of daily cigarette smoking, one or more quit attempts, shorter time to first cigarette of the day, and more severe withdrawal than the LNCG. The ADHD group did not appear to have better smoking cessation rates despite a higher proportion quitting at least once. Smoking quantity and nicotine dependence did not differ between groups. The ADHD group reported younger daily smoking onset and faster progression from smoking initiation to daily smoking across assessments. Finally, ADHD symptom severity in later adolescence and adulthood was associated with higher risk for daily smoking across assessments in the ADHD sample. CONCLUSIONS: This study shows that ADHD-related smoking risk begins at a young age, progresses rapidly, and becomes resistant to cessation attempts by adulthood. Prevention efforts should acknowledge the speed of uptake; treatments should target the higher relapse risk in this vulnerable population. IMPLICATIONS: Although childhood ADHD predicts later smoking, longitudinal studies of this population have yet to fully characterize smoking behaviors into adulthood that are known to be prognostic of long-term smoking outcome. The current study demonstrates earlier and faster progression to daily smoking among those with a childhood ADHD diagnosis, as well as greater risk for failed quit attempts. Prevention efforts should address speed of smoking uptake, while treatments are needed that address smoking relapse risk. The current study also demonstrates ADHD symptom severity over development increases daily smoking risk, implicating the need for continuous ADHD symptom management.
INTRODUCTION:Children with attention-deficit/hyperactivity disorder (ADHD) are at increased risk for smoking cigarettes, but there is little longitudinal research on the array of smoking characteristics known to be prognostic of long-term smoking outcomes into adulthood. These variables were studied into early adulthood in a multisite sample diagnosed with ADHD combined type at ages 7-9.9 and followed prospectively alongside an age- and sex-matched local normative comparison group (LNCG). METHODS: Cigarette smoking quantity, quit attempts, dependence, and other characteristics were assessed in the longitudinal Multimodal Treatment Study of Children with ADHD (MTA) eight times to a mean age of 24.9 years: ADHD n = 469; LNCG n = 240. RESULTS: In adulthood, the ADHD group had higher rates of daily cigarette smoking, one or more quit attempts, shorter time to first cigarette of the day, and more severe withdrawal than the LNCG. The ADHD group did not appear to have better smoking cessation rates despite a higher proportion quitting at least once. Smoking quantity and nicotine dependence did not differ between groups. The ADHD group reported younger daily smoking onset and faster progression from smoking initiation to daily smoking across assessments. Finally, ADHD symptom severity in later adolescence and adulthood was associated with higher risk for daily smoking across assessments in the ADHD sample. CONCLUSIONS: This study shows that ADHD-related smoking risk begins at a young age, progresses rapidly, and becomes resistant to cessation attempts by adulthood. Prevention efforts should acknowledge the speed of uptake; treatments should target the higher relapse risk in this vulnerable population. IMPLICATIONS: Although childhood ADHD predicts later smoking, longitudinal studies of this population have yet to fully characterize smoking behaviors into adulthood that are known to be prognostic of long-term smoking outcome. The current study demonstrates earlier and faster progression to daily smoking among those with a childhood ADHD diagnosis, as well as greater risk for failed quit attempts. Prevention efforts should address speed of smoking uptake, while treatments are needed that address smoking relapse risk. The current study also demonstrates ADHD symptom severity over development increases daily smoking risk, implicating the need for continuous ADHD symptom management.
Authors: Margaret H Sibley; William E Pelham; Brooke S G Molina; Elizabeth M Gnagy; Daniel A Waschbusch; Allison C Garefino; Aparajita B Kuriyan; Dara E Babinski; Kathryn M Karch Journal: J Consult Clin Psychol Date: 2011-12-12
Authors: F Joseph McClernon; Elizabeth E Van Voorhees; Joe English; Matt Hallyburton; Alex Holdaway; Scott H Kollins Journal: Nicotine Tob Res Date: 2011-05-12 Impact factor: 4.244
Authors: Joseph Biederman; Michael C Monuteaux; Eric Mick; Thomas Spencer; Timothy E Wilens; Julie M Silva; Lindsey E Snyder; Stephen V Faraone Journal: Psychol Med Date: 2006-02 Impact factor: 7.723
Authors: Lily Hechtman; James M Swanson; Margaret H Sibley; Annamarie Stehli; Elizabeth B Owens; John T Mitchell; L Eugene Arnold; Brooke S G Molina; Stephen P Hinshaw; Peter S Jensen; Howard B Abikoff; Guillermo Perez Algorta; Andrea L Howard; Betsy Hoza; Joy Etcovitch; Sylviane Houssais; Kimberley D Lakes; J Quyen Nichols Journal: J Am Acad Child Adolesc Psychiatry Date: 2016-09-02 Impact factor: 8.829
Authors: Brooke S G Molina; Stephen P Hinshaw; James M Swanson; L Eugene Arnold; Benedetto Vitiello; Peter S Jensen; Jeffery N Epstein; Betsy Hoza; Lily Hechtman; Howard B Abikoff; Glen R Elliott; Laurence L Greenhill; Jeffrey H Newcorn; Karen C Wells; Timothy Wigal; Robert D Gibbons; Kwan Hur; Patricia R Houck Journal: J Am Acad Child Adolesc Psychiatry Date: 2009-05 Impact factor: 8.829
Authors: Brooke S G Molina; Andrea L Howard; James M Swanson; Annamarie Stehli; John T Mitchell; Traci M Kennedy; Jeffery N Epstein; L Eugene Arnold; Lily Hechtman; Benedetto Vitiello; Betsy Hoza Journal: J Child Psychol Psychiatry Date: 2018-01-08 Impact factor: 8.982
Authors: Traci M Kennedy; Andrea L Howard; John T Mitchell; Betsy Hoza; L Eugene Arnold; Lily T Hechtman; James M Swanson; Annamarie Stehli; Brooke S G Molina Journal: Addict Behav Date: 2019-08-20 Impact factor: 3.913
Authors: John T Mitchell; F Joseph McClernon; Jean C Beckham; Richard A Brown; Carl W Lejuez; Scott H Kollins Journal: Drug Alcohol Depend Date: 2019-09-27 Impact factor: 4.492
Authors: Andrea L Howard; Traci M Kennedy; Erin P Macdonald; John T Mitchell; Margaret H Sibley; Arunima Roy; L Eugene Arnold; Jeffery N Epstein; Stephen P Hinshaw; Betsy Hoza; Annamarie Stehli; James M Swanson; Brooke S G Molina Journal: J Abnorm Child Psychol Date: 2019-12
Authors: Gyeyoon Yim; Andrea Roberts; Alberto Ascherio; David Wypij; Marianthi-Anna Kioumourtzoglou; And Marc G Weisskopf Journal: Epidemiology Date: 2022-05-01 Impact factor: 4.860
Authors: Waleed Ahmed Alghamdi; Faten N Alzaben; Hashem H Alhashemi; Saeed Sami Shaaban; Khawlah M Fairaq; Ahmed S Alsuliamani; Bsmah A Mahin; Radwan A Ghurab; Mohammad Gamal Sehlo; Harold G Koenig Journal: Saudi J Med Med Sci Date: 2022-04-28
Authors: Jacqueline M Vink; Jorien L Treur; Joëlle A Pasman; Arnt Schellekens Journal: Am J Med Genet B Neuropsychiatr Genet Date: 2020-09-10 Impact factor: 3.358
Authors: Lorenzo Zamboni; Pierpaolo Marchetti; Alessio Congiu; Rosaria Giordano; Francesca Fusina; Silvia Carli; Francesco Centoni; Giuseppe Verlato; Fabio Lugoboni Journal: Int J Environ Res Public Health Date: 2021-03-12 Impact factor: 3.390